Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells
- PMID: 9341765
- DOI: 10.1002/eji.1830270918
Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells
Abstract
Polarized human type 1 and type 2 T helper cells not only produce different sets of cytokines, but they also preferentially express certain activation markers, such as lymphocyte activation gene-3 (LAG-3) and CD30, respectively. In this study we have examined the LAG-3 and CD30 expression in relation to the lineage commitment of human naive CD4+ T cells, as assessed at the single-cell level of committed T cells. Purified CD45RA+ umbilical cord blood T lymphocytes were activated with phytohemagglutinin and interleukin (IL)-2 in the absence or presence of interleukin IL-4 or IL-12 and assessed for CD30 and LAG-3 expression, as well as for intracellular cytokine synthesis. Significant numbers of CD30+ cells were only found in CD4+ and CD8+ T lymphocytes of cultures primed with IL-4, which developed into cells able to produce IL-4 and IL-13 in addition to interferon (IFN)-gamma. By contrast, LAG-3 expression was strongly up-regulated in CD4+ and CD8+ T cells from cultures primed with IL-12, which developed into high numbers of IFN-gamma producers. The addition of a neutralizing anti-IFN-gamma antibody to IL-12-primed CD4+ T cell cultures virtually abolished the development of LAG-3-expressing CD4+ T cells. Taken together, these data suggest that CD30 expression is dependent on the presence of IL-4, whereas LAG-3 expression is dependent on the production of IFN-gamma during the lineage commitment of human naive T cells.
Similar articles
-
Lymphocyte activation gene-3 (LAG-3) expression and IFN-gamma production are variably coregulated in different human T lymphocyte subpopulations.J Immunol. 1998 Jul 1;161(1):489-93. J Immunol. 1998. PMID: 9647260
-
Lack of correlation between membrane CD30 expression and cytokine secretion pattern in allergen-primed naive cord blood T-cell lines and clones.Scand J Immunol. 1997 Apr;45(4):417-22. doi: 10.1046/j.1365-3083.1997.d01-416.x. Scand J Immunol. 1997. PMID: 9105430
-
Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.J Immunol. 1997 Feb 1;158(3):1085-94. J Immunol. 1997. PMID: 9013946
-
Endogenous IL-4 and IFN-gamma are essential for expression of Th2, but not Th1 cytokine message during the early differentiation of human CD4+ T helper cells.Hum Immunol. 2004 Nov;65(11):1328-35. doi: 10.1016/j.humimm.2004.06.007. Hum Immunol. 2004. PMID: 15556683
-
Interleukin 4: signalling mechanisms and control of T cell differentiation.Ciba Found Symp. 1997;204:208-16; discussion 216-9. doi: 10.1002/9780470515280.ch14. Ciba Found Symp. 1997. PMID: 9107423 Review.
Cited by
-
Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization.Front Immunol. 2021 Oct 7;12:754961. doi: 10.3389/fimmu.2021.754961. eCollection 2021. Front Immunol. 2021. PMID: 34691076 Free PMC article.
-
Altered Th1/Th2 commitment in human CD4+ T cells with ageing.Clin Exp Immunol. 2000 May;120(2):267-73. doi: 10.1046/j.1365-2249.2000.01224.x. Clin Exp Immunol. 2000. PMID: 10792375 Free PMC article.
-
LAG3's Enigmatic Mechanism of Action.Front Immunol. 2021 Jan 8;11:615317. doi: 10.3389/fimmu.2020.615317. eCollection 2020. Front Immunol. 2021. PMID: 33488626 Free PMC article. Review.
-
Understanding LAG-3 Signaling.Int J Mol Sci. 2021 May 17;22(10):5282. doi: 10.3390/ijms22105282. Int J Mol Sci. 2021. PMID: 34067904 Free PMC article. Review.
-
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.Front Immunol. 2022 Jan 17;12:785091. doi: 10.3389/fimmu.2021.785091. eCollection 2021. Front Immunol. 2022. PMID: 35111155 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials